I shopped for a number of sold out biotechs in December and picked and chose a number of sold out biotechs.
IOBT --I missed. But there are legs here. I have done well on four of my picks. Still waiting on two.
Time will tell.
Successful Trading is the art of minimizing long term risk and maximizing capital allocation.
Recent IOBT News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 12:30:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 12:13:53 PM
- IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights • GlobeNewswire Inc. • 05/14/2024 11:55:00 AM
- IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting • GlobeNewswire Inc. • 04/24/2024 08:30:00 PM
- IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness • GlobeNewswire Inc. • 04/15/2024 12:30:00 PM
- IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer Vaccine, IO102-IO103 • GlobeNewswire Inc. • 04/09/2024 04:00:00 PM
- IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer • GlobeNewswire Inc. • 04/05/2024 12:30:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/11/2024 08:56:44 PM
- IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting • GlobeNewswire Inc. • 03/06/2024 09:11:01 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/05/2024 10:17:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 09:46:56 PM
- IO Biotech Announces 2023 Fourth-Quarter and Year-End Results • GlobeNewswire Inc. • 03/05/2024 09:40:01 PM
- IO Biotech to Present at 44th Annual Cowen Health Care Conference • GlobeNewswire Inc. • 02/26/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:11:55 PM
- IO Biotech Announces First Patient Dosed in Phase 2 Neoadjuvant/Adjuvant Solid Tumor Basket Trial • GlobeNewswire Inc. • 12/21/2023 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/24/2023 10:37:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:15:37 PM
- IO Biotech Announces 2023 Third Quarter Results • GlobeNewswire Inc. • 11/13/2023 01:12:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 01:10:53 PM
- IO Biotech Appoints Helen Collins, MD, to its Board of Directors • GlobeNewswire Inc. • 11/13/2023 01:00:00 PM
- IO Biotech Completes Enrollment of 380 Patients in Pivotal Phase 3 Trial in Advanced Melanoma • GlobeNewswire Inc. • 11/10/2023 01:00:00 PM
- IO Biotech Announces Participation in Upcoming Investor Conferences • GlobeNewswire Inc. • 11/08/2023 09:30:00 PM
- IO Biotech Presents Three Posters at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting • GlobeNewswire Inc. • 11/01/2023 12:30:00 PM
- Encouraging Preliminary Data from a Phase 2 Trial Evaluating IO102-IO103 in Combination with Pembrolizumab for First-line Treatment of Patients with Non-small Cell Lung Cancer and Squamous Cell Carcinoma of the Head and Neck Presented at the European Socie • GlobeNewswire Inc. • 10/23/2023 05:00:00 AM
- IO Biotech Announces Three Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting • GlobeNewswire Inc. • 10/03/2023 08:30:00 PM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM